Exchange Traded Concepts LLC Grows Position in Kenvue Inc. $KVUE

Exchange Traded Concepts LLC raised its position in shares of Kenvue Inc. (NYSE:KVUE) by 45.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 94,431 shares of the company’s stock after acquiring an additional 29,401 shares during the period. Exchange Traded Concepts LLC’s holdings in Kenvue were worth $1,533,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of KVUE. Trust Co. of Vermont increased its position in Kenvue by 266.8% in the second quarter. Trust Co. of Vermont now owns 1,581 shares of the company’s stock worth $33,000 after purchasing an additional 1,150 shares during the last quarter. Truvestments Capital LLC purchased a new position in shares of Kenvue in the 1st quarter worth $37,000. First Pacific Financial bought a new stake in shares of Kenvue in the 2nd quarter worth about $54,000. Ransom Advisory Ltd purchased a new stake in shares of Kenvue during the 1st quarter valued at about $56,000. Finally, UMB Bank n.a. lifted its holdings in shares of Kenvue by 22.3% in the 2nd quarter. UMB Bank n.a. now owns 2,853 shares of the company’s stock valued at $60,000 after acquiring an additional 521 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Kenvue

In other news, Director Jeffrey C. Smith purchased 3,200,000 shares of the stock in a transaction that occurred on Friday, December 12th. The stock was purchased at an average price of $17.37 per share, for a total transaction of $55,584,000.00. Following the completion of the acquisition, the director owned 27,307,632 shares of the company’s stock, valued at approximately $474,333,567.84. This trade represents a 13.27% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 1.68% of the company’s stock.

Analyst Ratings Changes

Several brokerages have weighed in on KVUE. Zacks Research raised Kenvue from a “strong sell” rating to a “hold” rating in a research note on Wednesday, November 26th. Barclays increased their price target on Kenvue from $17.00 to $18.00 and gave the company an “equal weight” rating in a report on Monday, November 10th. Weiss Ratings restated a “hold (c-)” rating on shares of Kenvue in a research report on Tuesday, October 14th. Citigroup cut their price objective on shares of Kenvue from $20.00 to $17.00 and set a “neutral” rating on the stock in a research report on Thursday, October 9th. Finally, Rothschild Redb upgraded shares of Kenvue from a “hold” rating to a “strong-buy” rating in a report on Friday, September 26th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and twelve have given a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $20.23.

Kenvue Stock Performance

KVUE stock opened at $17.20 on Friday. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $25.17. The firm has a market cap of $32.95 billion, a price-to-earnings ratio of 22.93 and a beta of 0.60. The business’s fifty day simple moving average is $16.44 and its two-hundred day simple moving average is $18.73. The company has a quick ratio of 0.69, a current ratio of 0.98 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last posted its quarterly earnings results on Monday, November 3rd. The company reported $0.28 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.01. The firm had revenue of $3.76 billion for the quarter, compared to analysts’ expectations of $3.83 billion. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The business’s revenue for the quarter was down 3.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.28 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, November 26th. Stockholders of record on Wednesday, November 12th were given a dividend of $0.2075 per share. The ex-dividend date of this dividend was Wednesday, November 12th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.8%. Kenvue’s dividend payout ratio (DPR) is 110.67%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.